Clinical Trials Browser

Phase 2 × Disease Progression × 90 days × Clear all

NCT04954820 2026-06-04

ReLUTH

Phase 2 Recruiting

Neuroendocrine Tumors, Disease Progression

NCT05712356 2026-05-26

BOLSTER

Phase 2 Terminated

66 enrolled 12 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT07574684 2026-05-08

ALA /NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Disease Progression

NCT03259867 2026-04-16

TATE-PD1

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms, Disease Progression

NCT07514455 2026-04-07

RECOMEND

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression